Log in
Enquire now
‌

US Patent 11802131 Glutarimides for medical treatment

Patent 11802131 was granted and assigned to C4 Therapeutics on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
C4 Therapeutics
C4 Therapeutics
Current Assignee
C4 Therapeutics
C4 Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11802131
Patent Inventor Names
Annick Goergler
Philipp Schmid
Fabian Dey
Eric Andre Kusznir
Roger Norcross
Date of Patent
October 31, 2023
Patent Application Number
16809336
Date Filed
March 4, 2020
Patent Citations
‌
US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
‌
US Patent 10905768 Heterocyclic degronimers for target protein degradation
‌
US Patent 11185592 Spirocyclic degronimers for target protein degradation
‌
US Patent 11254672 Dihydrobenzimidazolones for medical treatment
‌
US Patent 11401256 Dihydroquinolinones for medical treatment
‌
US Patent 11407732 Tricyclic degraders of Ikaros and Aiolos
‌
US Patent 11459335 N/O-linked Degrons and Degronimers for protein degradation
‌
US Patent 11524949 Degraders and Degrons for targeted protein degradation
...
Patent Citations Received
0
Patent Primary Examiner
‌
Samantha L Shterengarts
Patent abstract

The present invention provides selected glutarimides which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11802131 Glutarimides for medical treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.